To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NCSTNTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
592 supporting clones for gene NCSTN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA477920   .a 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
AF240468   .a 208 to 3147 10 to 2949 exact tiling clone,   2940/2949
(99 %)
6 diff
(99.8 %id)
NM_015331.2   .a 217 to 3150 1 to 2934 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2934/2934
(100 %)
0 diff
(100 %id)
DN998176 breast cancer, Mammary gland (cancer tissue) .a 219 to 860 1 to 642       642/642
(100 %)
5 diff
(99.3 %id)
BI561908 testis .a 233 to 924 1 to 708       705/883
(79 %)
34 diff
(96.2 %id)
TI_44350441   .a 238 to 924 132 to 834       700/1009
(69 %)
35 diff
(96.6 %id)
DA027673   .a 242 to 815 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BG721491 testis .a 255 to 1074 1 to 825       825/841
(98 %)
26 diff
(97.0 %id)
DA574223   .a 259 to 811 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA857574 placenta .a 259 to 793 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
TI_154196847   .a 259 to 1153 12 to 898       887/1064
(83 %)
26 diff
(97.6 %id)
DB444030 testis .a 260 to 708 1 to 450       450/450
(100 %)
5 diff
(98.9 %id)
TI_44348630   .a 260 to 1004 87 to 830       744/833
(89 %)
25 diff
(97.0 %id)
DA373546 thalamus .a 261 to 800 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
TI_154195599   .a 261 to 1068 7 to 814       808/1068
(75 %)
22 diff
(98.0 %id)
TI_154195654   .a 261 to 1148 1 to 883       883/1035
(85 %)
15 diff
(98.6 %id)
BG720804 testis .a 264 to 979 1 to 710       712/711
(100 %)
14 diff
(98.1 %id)
TI_154196902   .a 264 to 1070 12 to 819       808/1083
(74 %)
12 diff
(98.9 %id)
TI_154197231   .a 266 to 1168 92 to 990       899/1019
(88 %)
12 diff
(98.9 %id)
DB456629 testis .a 272 to 759 1 to 490       490/490
(100 %)
6 diff
(98.8 %id)
TI_154197286   .a 272 to 1186 63 to 966       904/995
(90 %)
21 diff
(97.9 %id)
DA768016 brain .a 273 to 682 2 to 411   capped   410/410
(100 %)
0 diff
(100 %id)
DB483044 hippocampus .a 275 to 764 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
TI_44350098   .a 275 to 959 130 to 826       697/982
(70 %)
34 diff
(96.6 %id)
DB475988 hippocampus .a 278 to 763 1 to 486       486/486
(100 %)
6 diff
(98.8 %id)
DB477510 hippocampus .a 278 to 776 1 to 501       501/501
(100 %)
4 diff
(99.3 %id)
DB483154 hippocampus .a 278 to 770 1 to 493       493/493
(100 %)
4 diff
(99.2 %id)
TI_154195318   .a 278 to 1187 51 to 959       909/1075
(84 %)
13 diff
(98.8 %id)
DB075898 testis .a 279 to 745 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DB449781 testis .a 284 to 727 1 to 445       445/445
(100 %)
6 diff
(98.7 %id)
DA384280 thalamus .a 296 to 922 2 to 628   capped   627/633
(99 %)
2 diff
(99.7 %id)
BI464502 testis .a 304 to 1089 1 to 784       784/794
(98 %)
12 diff
(98.5 %id)
DA636899 Liver .a 306 to 1073 2 to 770   capped   769/878
(87 %)
9 diff
(99.0 %id)
BJ993618 hepatoblastoma .a 309 to 908 1 to 600       600/600
(100 %)
0 diff
(100 %id)
AK314764 placenta .a 310 to 2470 1 to 2161 exact     2161/2161
(100 %)
2 diff
(100.0 %id)
DA450576 tongue, tumor tissue .a 310 to 880 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA470787   .a 310 to 868 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA470810   .a 310 to 866 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA617316   .a 310 to 873 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA262489 caudate nucleus .a 311 to 888 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BI550939 brain, hippocampus .a 311 to 1090 1 to 778       778/778
(100 %)
11 diff
(98.6 %id)
DA856711 placenta .a 311 to 866 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA488020 brain .a 312 to 899 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA452875 tongue, tumor tissue .a 314 to 876 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AL710739 human skeletal muscle .a 314 to 842 1 to 529       529/529
(100 %)
0 diff
(100 %id)
TI_44172010   .a 314 to 1090 123 to 897       775/897
(86 %)
14 diff
(98.5 %id)
BX957118   .a 316 to 967 1 to 652       652/652
(100 %)
0 diff
(100 %id)
AL701916 human skeletal muscle .a 317 to 695 1 to 379       379/379
(100 %)
0 diff
(100 %id)
DB074045 testis .a 317 to 875 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA471751   .a 318 to 880 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA606784   .a 318 to 875 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA663259   .a 318 to 818 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DB144672 thymus .a 318 to 857 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BQ218962 leiomyosarcoma, uterus .a 321 to 1184 1 to 868       868/983
(88 %)
6 diff
(99.4 %id)
BG720318 testis .a 322 to 959 1 to 638       638/638
(100 %)
5 diff
(99.3 %id)
DA442855 tongue, tumor tissue .a 324 to 902 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB139611 thymus .a 324 to 861 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BI599277 brain, hypothalamus .a 325 to 1128 1 to 801       801/805
(99 %)
10 diff
(98.8 %id)
AU133372   .a 325 to 1163 2 to 840   capped   839/839
(100 %)
6 diff
(99.3 %id)
DA435657 tongue, tumor tissue .a 326 to 898 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
BM193464 leukopheresis .a 326 to 777 1 to 452       452/476
(94 %)
2 diff
(99.6 %id)
CB960413 Human Placenta, placenta .a 327 to 1020 28 to 728       701/798
(87 %)
17 diff
(97.9 %id)
BP283105 bone marrow .a 327 to 909 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP365721 lung .a 327 to 907 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BX501352 Liver .a 328 to 1038 1 to 711       711/711
(100 %)
3 diff
(99.6 %id)
BM149916 leukopheresis .a 328 to 654 1 to 326       326/364
(89 %)
25 diff
(93.2 %id)
DB279936 uterus .a 328 to 859 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BX951107   .a 329 to 1040 1 to 712       712/712
(100 %)
1 diff
(99.9 %id)
AL710919 human skeletal muscle .a 330 to 1156 1 to 829       829/830
(99 %)
4 diff
(99.6 %id)
BX956244   .a 330 to 941 1 to 613       613/613
(100 %)
4 diff
(99.4 %id)
DB443556 testis .a 330 to 551 1 to 222       222/222
(100 %)
4 diff
(98.2 %id)
TI_45212127   .a 330 to 1128 90 to 885       796/889
(89 %)
14 diff
(98.5 %id)
BP287291 lung .a 330 to 912 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP295214   .a 330 to 911 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AU127220   .a 330 to 916 2 to 588   capped   587/603
(97 %)
7 diff
(98.9 %id)
BP312433 mammary gland .a 330 to 912 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP313412 mammary gland .a 330 to 882 1 to 553       553/583
(94 %)
15 diff
(97.5 %id)
BP364248 lung .a 330 to 908 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
DA240027 brain .a 331 to 916 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA252865 caudate nucleus .a 331 to 897 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA260984 caudate nucleus .a 331 to 879 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA281213 corpus callosum .a 331 to 911 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA285606 corpus callosum .a 331 to 819 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
DA380444 thalamus .a 331 to 879 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA454167 tongue, tumor tissue .a 331 to 901 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA473430   .a 331 to 894 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA475759   .a 331 to 891 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA491382 brain .a 331 to 900 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA546069   .a 331 to 898 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA657254   .a 331 to 902 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA660898   .a 331 to 897 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA708867   .a 331 to 878 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA718358   .a 331 to 902 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AU132380   .a 331 to 1153 18 to 837   capped   820/821
(99 %)
7 diff
(99.2 %id)
DA738574   .a 331 to 1228 2 to 901   capped   900/900
(100 %)
12 diff
(98.7 %id)
DA748146   .a 331 to 869 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA750286   .a 331 to 898 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA750998   .a 331 to 908 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA765699 tongue .a 331 to 913 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA783437 brain .a 331 to 873 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA947223 Spleen .a 331 to 818 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA991210 synovial membrane tissue from rheumatioidarthritis .a 331 to 884 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA993817 synovial membrane tissue from rheumatioidarthritis .a 331 to 869 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB080483 testis .a 331 to 891 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB134677 thymus .a 331 to 899 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB157864 thymus .a 331 to 903 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB162280 thymus .a 331 to 934 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
DB191499 lung, tumor tissue .a 331 to 912 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DB240012 trachea .a 331 to 912 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CN429679 embryonic stem cells, DMSO-treated H9 cellline .a 332 to 1033 1 to 702       702/702
(100 %)
6 diff
(99.2 %id)
DB501199 hypothalamus .a 332 to 826 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
BP246802 Kidney .a 332 to 913 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BU146511 dorsal root ganglia .a 332 to 924 1 to 594       594/973
(61 %)
11 diff
(98.9 %id)
BP310259 brain .a 332 to 915 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP310297 brain .a 332 to 914 1 to 582       582/582
(100 %)
14 diff
(97.6 %id)
DA546191   .a 333 to 906 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB078867 testis .a 333 to 890 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA150407 amygdala .a 334 to 903 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA269833 caudate nucleus .a 334 to 877 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BF725852 eye, Iris .a 335 to 776 1 to 442       442/442
(100 %)
0 diff
(100 %id)
BX384067   .a 335 to 1209 1 to 875       875/875
(100 %)
2 diff
(99.8 %id)
BX508680   .a 335 to 986 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
CF780789 Pooled Chondrosarcoma Tumor cells .a 335 to 1110 1 to 774       774/967
(80 %)
12 diff
(98.8 %id)
CO402119 Chondrosarcoma Lung Metastasis cell lines, lung .a 335 to 928 37 to 614       578/719
(80 %)
32 diff
(95.6 %id)
TI_57240934   .a 336 to 1101 1 to 771       771/771
(100 %)
18 diff
(97.7 %id)
BQ073091 leukocyte .a 337 to 1071 1 to 740       740/1134
(65 %)
22 diff
(98.1 %id)
BM555002 duodenal adenocarcinoma, cell line, small intestine .a 338 to 1336 1 to 1006       1006/1006
(100 %)
27 diff
(97.4 %id)
DR762090 embryonic stem .a 338 to 1155 1 to 818       818/818
(100 %)
1 diff
(99.9 %id)
BM801973 eye, retinoblastoma .a 339 to 1171 1 to 841       841/1172
(71 %)
23 diff
(98.1 %id)
DA961095 Spleen .a 339 to 872 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB076331 testis .a 339 to 906 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AY359120   .a 340 to 3145 1 to 2806 exact     2806/2806
(100 %)
0 diff
(100 %id)
CN429687 embryonic stem cells, DMSO-treated H9 cellline .a 340 to 1094 1 to 755       755/755
(100 %)
4 diff
(99.5 %id)
BX335089 Placenta Cot 25-normalized .a 340 to 1282 1 to 934       934/977
(95 %)
16 diff
(98.4 %id)
TI_57177766   .a 340 to 1144 59 to 857       803/912
(88 %)
31 diff
(96.7 %id)
CD655535 Embryonic Stem cells .a 341 to 1073 8 to 739       732/829
(88 %)
11 diff
(98.7 %id)
BC100024 Chondrosarcoma, myxoid chondrosarcoma GradeII, mixture of 3 cell lines, enriched for 2-3 Kb mRNA .a 342 to 3145 1 to 2802   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2802/2802
(100 %)
1 diff
(100.0 %id)
CN429671 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 343 to 1150 1 to 808       808/808
(100 %)
0 diff
(100 %id)
CN429688 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 343 to 960 1 to 618       618/618
(100 %)
0 diff
(100 %id)
D87442 bone marrow .a 343 to 3147 1 to 2805   available from KIAA,   2805/2805
(100 %)
0 diff
(100 %id)
CN429680 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 344 to 1083 1 to 740       740/740
(100 %)
3 diff
(99.6 %id)
CO245445 Chondrosarcoma Lung Metastasis cell lines, lung .a 344 to 1090 1 to 738       740/847
(87 %)
16 diff
(98.2 %id)
CO247439 Chondrosarcoma Lung Metastasis cell lines, lung .a 347 to 1073 36 to 756       721/860
(83 %)
13 diff
(98.5 %id)
TI_154197956   .a 348 to 1296 99 to 1035       937/1015
(92 %)
17 diff
(98.4 %id)
CO246138 Chondrosarcoma Lung Metastasis cell lines, lung .a 349 to 1012 44 to 695       652/778
(83 %)
65 diff
(91.7 %id)
CO247506 Chondrosarcoma Lung Metastasis cell lines, lung .a 349 to 1052 47 to 748       702/752
(93 %)
15 diff
(98.1 %id)
TI_154195022   .a 349 to 1234 51 to 928       878/963
(91 %)
12 diff
(98.8 %id)
TI_154196324   .a 350 to 1186 21 to 853       833/1076
(77 %)
19 diff
(98.3 %id)
CN429677 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 352 to 1082 8 to 738       731/738
(99 %)
6 diff
(99.2 %id)
CF125308 Chondrosarcoma Lung Metastasis cell lines, lung .a 353 to 1151 1 to 793       793/813
(97 %)
11 diff
(98.7 %id)
TI_154186845   .a 353 to 1151 44 to 836       793/997
(79 %)
11 diff
(98.9 %id)
TI_57179737   .a 359 to 1091 25 to 753       731/754
(96 %)
11 diff
(98.6 %id)
DR761474 embryonic stem .a 361 to 1145 1 to 785       785/785
(100 %)
0 diff
(100 %id)
BU183913 melanotic melanoma, skin .a 362 to 1184 1 to 828       828/860
(96 %)
13 diff
(98.5 %id)
CX867559 embryonic stem .a 363 to 1203 1 to 841     Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 841/841
(100 %)
1 diff
(99.9 %id)
BI770467 pooled lung and spleen .a 364 to 1091 1 to 724       726/725
(100 %)
5 diff
(99.4 %id)
CO248038 Chondrosarcoma Lung Metastasis cell lines, lung .a 368 to 1108 1 to 735       735/826
(88 %)
18 diff
(97.9 %id)
AA486319   .a 370 to 545 1 to 176       176/176
(100 %)
0 diff
(100 %id)
TI_154194984   .a 370 to 1173 51 to 842       792/983
(80 %)
16 diff
(98.4 %id)
DA574616   .a 382 to 958 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA390122 thalamus .a 404 to 975 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
TI_154186308   .a 430 to 1156 50 to 776       727/728
(99 %)
8 diff
(99.0 %id)
CF124943 Chondrosarcoma Lung Metastasis cell lines, lung .a 431 to 1130 1 to 702       702/706
(99 %)
3 diff
(99.6 %id)
CO247380 Chondrosarcoma Lung Metastasis cell lines, lung .a 441 to 1180 1 to 729       729/822
(88 %)
17 diff
(98.0 %id)
TI_154197996   .a 453 to 1337 85 to 959       875/981
(89 %)
21 diff
(97.9 %id)
DA393485 thalamus .a 461 to 1057 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
CO246513 Chondrosarcoma Lung Metastasis cell lines, lung .a 463 to 1173 8 to 713       706/818
(86 %)
16 diff
(98.1 %id)
DA450115 tongue, tumor tissue .a 464 to 1030 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CF125735 Chondrosarcoma Lung Metastasis cell lines, lung .a 466 to 1180 1 to 715       715/719
(99 %)
2 diff
(99.8 %id)
TI_154186576   .a 466 to 1202 51 to 786       736/740
(99 %)
4 diff
(99.5 %id)
BU956982 adenocarcinoma, cell line, breast .a 480 to 1260 1 to 789       789/925
(85 %)
16 diff
(98.3 %id)
BI045321 prostate_normal .a 486 to 1070 597 to 13       586/597
(98 %)
0 diff
(100 %id)
DN994608 brain, whole brain .a 527 to 1351 1 to 822       822/833
(98 %)
12 diff
(98.6 %id)
DA950204 Spleen .a 537 to 1094 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CO247249 Chondrosarcoma Lung Metastasis cell lines, lung .a 558 to 1306 1 to 745       745/780
(95 %)
15 diff
(98.1 %id)
BM556549 duodenal adenocarcinoma, cell line, small intestine .a 584 to 1340 1 to 762       762/1019
(74 %)
8 diff
(99.3 %id)
EH335019   .a 622 to 691 1 to 70       70/70
(100 %)
0 diff
(100 %id)
CD652252 Embryonic Stem cells .a 625 to 1442 4 to 820       817/820
(99 %)
14 diff
(98.3 %id)
BE788789 large cell carcinoma, lung .a 643 to 1337 1 to 688       690/820
(84 %)
13 diff
(98.5 %id)
BE177215 head_neck .a 670 to 992 342 to 19     Submitted on the opposite strand 324/344
(94 %)
3 diff
(99.2 %id)
AA248320   .a 682 to 1011 1 to 330       330/330
(100 %)
0 diff
(100 %id)
DA874075 Prostate .a 690 to 1253 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DR158862 human embryonic stem cells differentiated toan early endodermal cell type .a 701 to 1493 1 to 793       793/793
(100 %)
0 diff
(100 %id)
Z19131   .a 737 to 1052 1 to 314       314/317
(99 %)
30 diff
(90.6 %id)
CF619402 Pooled Chondrosarcoma Tumor cells .a 752 to 1500 1 to 753       751/906
(82 %)
12 diff
(98.7 %id)
BM152989 leukopheresis .a 765 to 1144 1 to 380       380/380
(100 %)
11 diff
(97.2 %id)
DA424275   .a 780 to 1346 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA424292   .a 780 to 1344 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB181853 liver, tumor tissue .a 787 to 1281 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
BQ225025 epithelioid carcinoma, Pancreas .a 800 to 1653 1 to 863       863/864
(99 %)
17 diff
(98.1 %id)
BU940192 mixed (pool of 40 RNAs) .a 819 to 1520 1 to 706       706/768
(91 %)
9 diff
(98.9 %id)
CN429682 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 833 to 1486 1 to 654       654/654
(100 %)
5 diff
(99.3 %id)
BQ301148 bocio_tumor .a 838 to 1053 214 to 2       213/214
(99 %)
2 diff
(99.1 %id)
BI669892 brain, hypothalamus .a 850 to 1679 1 to 831       831/831
(100 %)
18 diff
(97.9 %id)
TI_44344426   .a 853 to 1679 85 to 912       828/912
(90 %)
20 diff
(97.9 %id)
BM144658 leukopheresis .a 885 to 1354 470 to 1       470/471
(99 %)
2 diff
(99.6 %id)
BE709438 head_neck .a 969 to 1521 563 to 11       555/563
(98 %)
28 diff
(95.1 %id)
DB474462 hippocampus .a 978 to 1461 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BE709819 head_neck .a 995 to 1525 532 to 1       534/532
(100 %)
10 diff
(98.2 %id)
DA662351   .a 995 to 1561 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BE709847 head_neck .a 1001 to 1527 530 to 4       531/530
(100 %)
1 diff
(99.9 %id)
BX419785 brain, fetal brain .a 1024 to 1918 1 to 895       895/895
(100 %)
2 diff
(99.8 %id)
AW602431 breast .a 1055 to 1336 322 to 35       288/322
(89 %)
0 diff
(100 %id)
BE709597 head_neck .a 1057 to 1527 487 to 17       475/487
(97 %)
0 diff
(100 %id)
BE709648 head_neck .a 1080 to 1447 372 to 6       366/372
(98 %)
8 diff
(97.9 %id)
BE179384 head_neck .a 1081 to 1427 352 to 6     Submitted on the opposite strand 347/352
(98 %)
0 diff
(100 %id)
CN429686 embryonic stem cells, DMSO-treated H9 cellline .a 1105 to 1699 1 to 595       595/595
(100 %)
5 diff
(99.2 %id)
BF375675 stomach .a 1111 to 1713 604 to 1       604/604
(100 %)
5 diff
(99.2 %id)
BP358955 mammary gland .a 1118 to 1699 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE709560 head_neck .a 1122 to 1527 422 to 17       410/422
(97 %)
1 diff
(99.8 %id)
BE408912 choriocarcinoma, placenta .a 1136 to 1859 1 to 726       726/807
(89 %)
28 diff
(96.6 %id)
AA486217   .a 1156 to 1359 204 to 1       204/204
(100 %)
2 diff
(99.1 %id)
ES313497 beard hair, skin .a 1183 to 1692 1 to 509       509/518
(98 %)
9 diff
(98.3 %id)
BP291613 lung .a 1190 to 1771 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AW610189 stomach .a 1246 to 1721 479 to 4       476/479
(99 %)
4 diff
(99.2 %id)
F12521 brain, total brain .a 1284 to 1525 1 to 242       242/242
(100 %)
0 diff
(100 %id)
DB474850 hippocampus .a 1288 to 1779 1 to 492       492/492
(100 %)
0 diff
(100 %id)
DB483133 hippocampus .a 1288 to 1770 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BX372291   .a 1341 to 2273 941 to 1       939/941
(99 %)
25 diff
(97.4 %id)
BU855010 ovary, teratocarcinoma, cell line .a 1343 to 2133 1 to 792       792/914
(86 %)
4 diff
(99.6 %id)
DA340791 substantia nigra .a 1351 to 1912 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
F12075 brain, total brain .a 1359 to 1741 1 to 383       383/383
(100 %)
0 diff
(100 %id)
AI460370 brain, oligodendroglioma .a 1366 to 1846 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
TI_154170728   .a 1381 to 2038 98 to 759       662/948
(69 %)
11 diff
(98.9 %id)
CX788897 human embryonic stem cells .a 1469 to 2281 1 to 813       813/813
(100 %)
2 diff
(99.8 %id)
CN429669 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1477 to 2197 1 to 721       721/724
(99 %)
1 diff
(99.9 %id)
BG489641 large cell carcinoma, lung .a 1521 to 2351 1 to 830       830/853
(97 %)
16 diff
(98.2 %id)
M78914   .a 1555 to 1882 1 to 328       328/328
(100 %)
0 diff
(100 %id)
CB146454 Liver .a 1600 to 1796 1 to 197       197/201
(98 %)
27 diff
(86.6 %id)
BQ716175 sympathetic trunk .a 1604 to 2351 1 to 750       750/867
(86 %)
11 diff
(98.8 %id)
T32980 brain .a 1608 to 2030 20 to 442       423/444
(95 %)
10 diff
(97.8 %id)
CR605263 Placenta Cot 25-normalized .a 1626 to 3117 1 to 1492       1492/1492
(100 %)
0 diff
(100 %id)
BG763047 melanotic melanoma, high MDR (cell line), skin .a 1633 to 2372 1 to 740       740/740
(100 %)
2 diff
(99.8 %id)
BG767965 melanotic melanoma, high MDR (cell line), skin .a 1633 to 2410 1 to 777       777/777
(100 %)
4 diff
(99.5 %id)
BX382586 Placenta Cot 25-normalized .a 1641 to 2591 14 to 961       948/967
(98 %)
16 diff
(98.4 %id)
BX386476 Placenta Cot 25-normalized .a 1641 to 2624 1 to 981       981/981
(100 %)
3 diff
(99.7 %id)
TI_154172326   .a 1641 to 2277 90 to 734       645/1097
(58 %)
26 diff
(97.7 %id)
BM049858 carcinoma, cell line, Prostate .a 1654 to 2453 1 to 798       798/799
(99 %)
8 diff
(99.0 %id)
BQ944698 carcinoma, cell line, Prostate .a 1656 to 2585 1 to 936       936/939
(99 %)
15 diff
(98.5 %id)
CK819188 Islets of Langerhans, Pancreas .a 1689 to 2278 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BG696845 skin .a 1704 to 2443 1 to 739       739/739
(100 %)
1 diff
(99.9 %id)
CN429692 embryonic stem cells, cell lines H1, H7, andH9 .a 1705 to 2302 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM128161 Islets of Langerhans, Pancreas .a 1705 to 2302 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM128652 Islets of Langerhans, Pancreas .a 1705 to 2296 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BE179850 head_neck .a 1708 to 2201 510 to 17     Submitted on the opposite strand 494/510
(96 %)
1 diff
(99.9 %id)
BQ215491 large cell carcinoma, lung .a 1717 to 2573 1 to 859       859/870
(98 %)
8 diff
(99.1 %id)
BM471625 eye, retinoblastoma .a 1719 to 2696 1 to 991       991/1028
(96 %)
36 diff
(96.5 %id)
BI090293 cervix .a 1726 to 2593 1 to 865       865/868
(99 %)
20 diff
(97.7 %id)
T32024 uterus .a 1738 to 1899 1 to 162       162/162
(100 %)
0 diff
(100 %id)
BU161802 melanotic melanoma, skin .a 1747 to 2571 1 to 830       830/831
(99 %)
8 diff
(99.1 %id)
BF374893 stomach .a 1751 to 1885 135 to 1       135/135
(100 %)
0 diff
(100 %id)
BU542496 carcinoma, cell line, Prostate .a 1765 to 2681 1 to 925       925/925
(100 %)
10 diff
(99.0 %id)
BF339787 brain, glioblastoma with EGFR amplification .a 1768 to 2537 1 to 773       773/914
(84 %)
18 diff
(98.1 %id)
BI868724 adenocarcinoma, cell line, Liver .a 1768 to 2537 10 to 778       769/778
(98 %)
7 diff
(99.2 %id)
TI_57227784   .a 1768 to 2537 34 to 802       769/778
(98 %)
7 diff
(99.2 %id)
BE181569 head_neck .a 1802 to 2097 300 to 2     Submitted on the opposite strand 299/300
(99 %)
1 diff
(99.7 %id)
AW386734 pnet .a 1819 to 2435 618 to 2       617/618
(99 %)
4 diff
(99.4 %id)
BU602580 mixed (pool of 40 RNAs) .a 1828 to 2577 1 to 758       758/798
(94 %)
16 diff
(98.0 %id)
AW372837 breast .a 1831 to 2471 639 to 3       637/639
(99 %)
8 diff
(98.8 %id)
BG910676 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1831 to 2708 1 to 884       844/909
(92 %)
18 diff
(98.1 %id)
BM919007 pooled pancreas and spleen .a 1837 to 2737 20 to 935       916/1071
(85 %)
25 diff
(97.7 %id)
CA394641 eye, RPE/choroid .a 1891 to 2561 10 to 680       671/680
(98 %)
7 diff
(99.0 %id)
BE709792 head_neck .a 1893 to 2201 309 to 1       309/309
(100 %)
5 diff
(98.4 %id)
CN429684 embryonic stem cells, cell lines H1, H7, andH9 .a 1897 to 2547 1 to 651       651/651
(100 %)
2 diff
(99.7 %id)
TI_57230699   .a 1898 to 2571 88 to 758       671/671
(100 %)
3 diff
(99.6 %id)
BI869107 adenocarcinoma, cell line, Liver .a 1899 to 2571 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
BF530600 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1911 to 2678 1 to 753       753/934
(80 %)
22 diff
(97.7 %id)
FN164548 breast carcinoma .a 1945 to 2050 1 to 108       108/108
(100 %)
4 diff
(96.3 %id)
BF741438 bocio_tumor .a 1972 to 2238 292 to 29     Submitted on the opposite strand 264/292
(90 %)
0 diff
(100 %id)
AW962601   .a 1974 to 2525 550 to 1     Submitted on the opposite strand 550/567
(97 %)
15 diff
(97.4 %id)
CN429674 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1986 to 2704 1 to 721       721/721
(100 %)
7 diff
(99.1 %id)
AI909011 breast .a 1997 to 2304 320 to 12       309/322
(95 %)
5 diff
(98.5 %id)
BM850527 stomach .a 2011 to 2624 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CN429681 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2019 to 2740 1 to 722       722/722
(100 %)
2 diff
(99.8 %id)
W03093 melanocyte .a 2031 to 2325 1 to 295       295/295
(100 %)
5 diff
(98.4 %id)
EC461146 Prostate .a 2044 to 2127 83 to 2       82/93
(88 %)
0 diff
(100 %id)
EC535228 Prostate .a 2044 to 2122 79 to 1       79/89
(88 %)
1 diff
(98.9 %id)
EC579548 Prostate .a 2044 to 2122 78 to 1       78/88
(88 %)
2 diff
(97.8 %id)
AI743213 pooled .a 2069 to 2287 219 to 1       219/219
(100 %)
0 diff
(100 %id)
BF094960 uterus_tumor .a 2071 to 2393 326 to 7       320/340
(94 %)
1 diff
(99.8 %id)
BF912341 uterus_tumor .a 2071 to 2319 288 to 36     Submitted on the opposite strand 253/302
(83 %)
0 diff
(100 %id)
BF913764 uterus_tumor .a 2071 to 2347 323 to 45     Submitted on the opposite strand 277/352
(78 %)
0 diff
(100 %id)
BQ379622 uterus_tumor .a 2071 to 2395 327 to 4       325/341
(95 %)
3 diff
(99.2 %id)
BG990729 head_neck .a 2092 to 2389 311 to 8       304/315
(96 %)
8 diff
(97.5 %id)
BE262466 brain, neuroblastoma .a 2093 to 2797 744 to 41     Submitted on the opposite strand 704/748
(94 %)
0 diff
(100 %id)
BE158319 head_neck .a 2098 to 2696 609 to 10     Submitted on the opposite strand 600/609
(98 %)
1 diff
(99.9 %id)
BX363973   .a 2100 to 3118 1019 to 1       1019/1019
(100 %)
2 diff
(99.9 %id)
AW376407 colon .a 2104 to 2351 271 to 22       250/271
(92 %)
2 diff
(99.3 %id)
AW369337 breast_normal .a 2115 to 2708 600 to 11       593/600
(98 %)
9 diff
(98.5 %id)
AW880964 ovary .a 2118 to 2401 285 to 1       285/285
(100 %)
2 diff
(99.3 %id)
CN429673 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2122 to 2773 1 to 652       652/652
(100 %)
0 diff
(100 %id)
BX335088 Placenta Cot 25-normalized .a 2163 to 3121 958 to 1       958/961
(99 %)
18 diff
(98.2 %id)
BX384066   .a 2188 to 3120 936 to 4       933/936
(99 %)
0 diff
(100 %id)
EC497425 Prostate .a 2208 to 2302 95 to 1       95/95
(100 %)
5 diff
(94.8 %id)
DB310100 substantia nigra .a 2614 to 3145 538 to 3       536/538
(99 %)
0 diff
(100 %id)
DB321082 Liver .a 2622 to 3147 527 to 1       527/529
(99 %)
7 diff
(98.7 %id)
CX867479 embryonic stem .a 2656 to 3145 519 to 30   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 490/493
(99 %)
0 diff
(100 %id)
N72872 melanocyte .a 2725 to 3144 418 to 1       418/418
(100 %)
4 diff
(99.1 %id)
F09714 brain, total brain .a 2805 to 3145 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
F10139 brain, total brain .a 2806 to 3145 340 to 1       340/340
(100 %)
2 diff
(99.5 %id)
AU153910   .a 2915 to 3150 236 to 1   tiling clone,   236/236
(100 %)
2 diff
(99.2 %id)
BG721666 testis .b 1 to 645 5 to 649   tiling clone,   649/649
(100 %)
4 diff
(99.4 %id)
BC047621 testis .b 2 to 3026 1 to 3025 R637H tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3025/3025
(100 %)
1 diff
(100.0 %id)
DB462411 testis .b 2 to 480 1 to 479       479/479
(100 %)
0 diff
(100 %id)
FN133761 breast carcinoma .b 182 to 272 92 to 2     Submitted on the opposite strand 91/93
(97 %)
0 diff
(100 %id)
EL733942 mixed .b 282 to 944 1 to 663       663/663
(100 %)
0 diff
(100 %id)
TI_1948156992   .b 282 to 1324 139 to 1172       1034/1369
(75 %)
30 diff
(97.9 %id)
TI_1948157145   .b 282 to 1306 136 to 1154       1019/1340
(76 %)
29 diff
(97.9 %id)
TI_1948157307   .b 282 to 1324 140 to 1179       1040/1364
(76 %)
24 diff
(98.3 %id)
TI_1948157467   .b 282 to 1323 138 to 1176       1039/1366
(76 %)
33 diff
(97.6 %id)
TI_1948157146   .b 1348 to 2350 1132 to 128       1005/1142
(88 %)
27 diff
(97.7 %id)
TI_1948156993   .b 1395 to 2350 1092 to 127       966/1149
(84 %)
30 diff
(97.4 %id)
TI_1948157308   .b 1396 to 2350 1095 to 127       969/1165
(83 %)
31 diff
(97.4 %id)
TI_1948157468   .b 1436 to 2350 1053 to 125       928/1198
(77 %)
33 diff
(97.3 %id)
BE833695 ovary .b 2223 to 2457 244 to 7       238/261
(91 %)
0 diff
(100 %id)
BF340237 brain, glioblastoma with EGFR amplification .b 2229 to 2981 1 to 742       742/910
(81 %)
11 diff
(98.8 %id)
AW805004 uterus .b 2235 to 2779 1 to 545       545/546
(99 %)
6 diff
(99.0 %id)
AW839192 leiomios .b 2236 to 2664 435 to 7       429/435
(98 %)
0 diff
(100 %id)
BE158330 head_neck .b 2236 to 2367 140 to 10     Submitted on the opposite strand 131/140
(93 %)
0 diff
(100 %id)
AW804985 uterus .b 2237 to 2770 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
DB478597 hippocampus .b 2239 to 2696 1 to 458       458/458
(100 %)
0 diff
(100 %id)
AW581360 leiomios .b 2245 to 2641 398 to 3       396/398
(99 %)
0 diff
(100 %id)
AW839198 leiomios .b 2245 to 2676 436 to 5       432/436
(99 %)
0 diff
(100 %id)
BI020890 marrow .b 2245 to 2383 151 to 13       139/151
(92 %)
0 diff
(100 %id)
AI377767 pooled .b 2247 to 3027 784 to 3       782/784
(99 %)
0 diff
(100 %id)
BM724742 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2248 to 2950 1 to 701       701/701
(100 %)
2 diff
(99.8 %id)
BE878476 large cell carcinoma, undifferentiated, lung .b 2250 to 2849 1 to 602       602/602
(100 %)
8 diff
(98.7 %id)
BU168934 melanotic melanoma, cell line, skin .b 2251 to 3031 15 to 806   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 792/806
(98 %)
6 diff
(99.3 %id)
BU180141 melanotic melanoma, cell line, skin .b 2252 to 3031 17 to 796   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 780/796
(97 %)
6 diff
(99.3 %id)
N30452 melanocyte .b 2254 to 2639 1 to 387   fully sequenced,   387/387
(100 %)
3 diff
(99.3 %id)
ES309344 occipital hair of pubic hypotrichosispatient, skin .b 2274 to 2993 26 to 746       721/747
(96 %)
18 diff
(97.6 %id)
BM745836 stomach .b 2284 to 2879 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BU625512 cell lines, Enchondroma .b 2287 to 3026 758 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 740/740
(100 %)
0 diff
(100 %id)
BU634039 cell lines, Chondrosarcoma .b 2287 to 3026 757 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 739/739
(100 %)
1 diff
(99.9 %id)
CA306473 Alveolar Macrophage, lung .b 2287 to 3026 758 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 740/740
(100 %)
0 diff
(100 %id)
BE768693 prostate_tumor .b 2288 to 2688 408 to 8       401/408
(98 %)
0 diff
(100 %id)
H02166 placenta .b 2288 to 2687 1 to 405   fully sequenced,   405/405
(100 %)
9 diff
(97.8 %id)
TI_149295360   .b 2288 to 3028 821 to 86   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 736/922
(79 %)
47 diff
(95.0 %id)
TI_149303708   .b 2289 to 3026 824 to 87   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 738/958
(77 %)
1 diff
(99.9 %id)
BM981668 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 2289 to 3026 756 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 738/749
(98 %)
1 diff
(99.9 %id)
BF569485 Kidney, renal carcinoma (ascites) .b 2295 to 3026 1 to 726   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 726/726
(100 %)
12 diff
(98.4 %id)
BQ775854 Bone, Human Chondrosarcoma Cell Line .b 2296 to 3026 747 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 729/729
(100 %)
6 diff
(99.2 %id)
BF031125 hypernephroma, Kidney .b 2303 to 2836 1 to 537       537/538
(99 %)
14 diff
(97.4 %id)
CV570840 cornea, eye .b 2307 to 2869 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BG818744 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2315 to 2954 1 to 640       640/651
(98 %)
1 diff
(99.9 %id)
BE768699 prostate_tumor .b 2319 to 2688 376 to 8       369/376
(98 %)
0 diff
(100 %id)
CN429676 embryonic stem cells, DMSO-treated H9 cellline .b 2319 to 2970 1 to 652       652/652
(100 %)
4 diff
(99.4 %id)
TI_154062127   .b 2321 to 3026 795 to 94   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 702/764
(91 %)
6 diff
(99.3 %id)
CD369056 Alveolar Macrophage, lung .b 2325 to 3028 718 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 702/702
(100 %)
2 diff
(99.8 %id)
CD364646 Alveolar Macrophage, lung .b 2325 to 3026 720 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 702/702
(100 %)
0 diff
(100 %id)
EC445224 Prostate .b 2327 to 2421 99 to 5       95/101
(94 %)
0 diff
(100 %id)
BI259664 cervical carcinoma cell line, cervix .b 2338 to 3032 1 to 695       695/712
(97 %)
7 diff
(99.1 %id)
BG770646 melanotic melanoma, high MDR (cell line), skin .b 2339 to 3029 1 to 691       691/717
(96 %)
17 diff
(97.7 %id)
BG765068 melanotic melanoma, high MDR (cell line), skin .b 2339 to 3021 1 to 686   AAA   686/693
(98 %)
9 diff
(98.8 %id)
CA421029 Bone, Enchondroma cell line .b 2340 to 3026 703 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 685/685
(100 %)
4 diff
(99.5 %id)
FN093076 breast carcinoma .b 2345 to 2396 52 to 1     Submitted on the opposite strand 52/53
(98 %)
0 diff
(100 %id)
BM044420 carcinoma, cell line, Prostate .b 2357 to 2912 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BM048798 carcinoma, cell line, Prostate .b 2357 to 3028 1 to 669   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 669/669
(100 %)
3 diff
(99.6 %id)
BQ006791 Chondrosarcoma, Left Pelvis .b 2359 to 3003 667 to 24       644/667
(96 %)
0 diff
(100 %id)
BU541961 carcinoma, cell line, Prostate .b 2361 to 3026 1 to 668       668/963
(69 %)
6 diff
(99.4 %id)
BU954647 mixed (pool of 40 RNAs) .b 2366 to 3022 1 to 659       659/670
(98 %)
7 diff
(99.0 %id)
BM674272 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2373 to 3028 672 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 656/656
(100 %)
0 diff
(100 %id)
CA418974 Chondrosarcoma Grade II, Left Pelvis .b 2375 to 3026 670 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 652/652
(100 %)
0 diff
(100 %id)
T25151   .b 2384 to 2577 192 to 1       192/192
(100 %)
2 diff
(99.0 %id)
BG960963 colon .b 2395 to 2649 262 to 1       262/275
(95 %)
12 diff
(95.7 %id)
TI_149309595   .b 2398 to 3026 717 to 88   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 630/962
(65 %)
5 diff
(99.5 %id)
BU687978 lung .b 2398 to 3026 648 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 630/630
(100 %)
5 diff
(99.3 %id)
R70659 placenta .b 2406 to 2822 10 to 430   fully sequenced,   421/430
(97 %)
16 diff
(96.3 %id)
BM717561 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2417 to 2931 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BF035344 adenocarcinoma, ovary .b 2422 to 3017 598 to 1     Submitted on the opposite strand 598/598
(100 %)
3 diff
(99.5 %id)
BE932052 head_neck .b 2433 to 2666 236 to 3       234/236
(99 %)
0 diff
(100 %id)
R35228 placenta .b 2435 to 2718 1 to 291   fully sequenced,   291/291
(100 %)
0 diff
(100 %id)
R67774 placenta .b 2435 to 2782 1 to 357   fully sequenced,   357/357
(100 %)
6 diff
(98.4 %id)
BE890486 melanotic melanoma, skin .b 2438 to 3022 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
AA522792 lung, lung tumor .b 2449 to 3026 568 to 1       568/569
(99 %)
14 diff
(97.6 %id)
AA419288 ovarian tumor, ovary .b 2452 to 2906 1 to 455       455/455
(100 %)
14 diff
(97.0 %id)
AA126613 uterus .b 2456 to 3004 1 to 541   fully sequenced,   541/541
(100 %)
17 diff
(96.9 %id)
CK819187 Islets of Langerhans, Pancreas .b 2458 to 3026 569 to 1       569/569
(100 %)
1 diff
(99.9 %id)
W95967 heart .b 2463 to 2904 1 to 447       447/487
(91 %)
10 diff
(98.0 %id)
AJ706363 bone marrow .b 2468 to 2908 1 to 439       439/439
(100 %)
5 diff
(98.9 %id)
BQ001496 lung, Metastatic Chondrosarcoma .b 2469 to 3028 576 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 560/560
(100 %)
2 diff
(99.7 %id)
BM691771 eye, human retina .b 2470 to 2625 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BM715143 eye, human retina .b 2470 to 3026 1 to 557   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 557/557
(100 %)
0 diff
(100 %id)
AA461588   .b 2484 to 2822 1 to 338   fully sequenced,   338/338
(100 %)
0 diff
(100 %id)
CN429672 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2485 to 3031 1 to 547   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 547/547
(100 %)
1 diff
(99.9 %id)
BM127864 Islets of Langerhans, Pancreas .b 2490 to 3026 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
BM701363 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2497 to 2851 34 to 388       355/388
(91 %)
13 diff
(96.7 %id)
BM717114 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2497 to 3031 34 to 568   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 535/568
(94 %)
6 diff
(99.0 %id)
T73170 Liver .b 2498 to 2769 1 to 280   fully sequenced,   280/280
(100 %)
3 diff
(99.0 %id)
AW020517 cochlea, ear .b 2499 to 3016 8 to 525       518/525
(98 %)
6 diff
(98.9 %id)
BQ001543 lung, Metastatic Chondrosarcoma .b 2499 to 3028 546 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 530/534
(99 %)
2 diff
(99.7 %id)
AI903719 breast .b 2500 to 2727 256 to 28       229/256
(89 %)
0 diff
(100 %id)
BM980260 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 2510 to 3028 537 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 521/521
(100 %)
4 diff
(99.3 %id)
AI827923 pooled .b 2515 to 3026 524 to 13   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 512/512
(100 %)
6 diff
(98.9 %id)
BM995445 Chondrosarcoma, Left Pubic Bone .b 2523 to 3026 524 to 21   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 504/506
(99 %)
0 diff
(100 %id)
FN092384 breast carcinoma .b 2527 to 2592 1 to 64       64/65
(98 %)
3 diff
(95.4 %id)
DB550807 hippocampus .b 2530 to 3026 1 to 497     Submitted on the opposite strand 497/497
(100 %)
2 diff
(99.6 %id)
CB854860 lung .b 2533 to 3028 512 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 496/496
(100 %)
8 diff
(98.4 %id)
BG236398 blood, lymphocyte .b 2534 to 3029 498 to 3       496/498
(99 %)
0 diff
(100 %id)
CF780610 Pooled Chondrosarcoma Tumor cells .b 2534 to 3027 1 to 494       494/497
(99 %)
6 diff
(98.8 %id)
CN485093 eye .b 2535 to 3027 1 to 493       493/523
(94 %)
1 diff
(99.9 %id)
AA506719 colon .b 2536 to 3029 493 to 1       493/493
(100 %)
4 diff
(99.2 %id)
TI_154004603   .b 2537 to 3028 605 to 114   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 492/500
(98 %)
1 diff
(99.8 %id)
TI_154105208   .b 2537 to 3026 570 to 83   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 488/493
(98 %)
5 diff
(99.0 %id)
DB522048 testis .b 2538 to 3026 1 to 489     Submitted on the opposite strand 489/489
(100 %)
1 diff
(99.8 %id)
CB044998 colon, juvenile granulosa tumor .b 2538 to 3028 508 to 18   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
BM998542 lung, Metastatic Chondrosarcoma .b 2540 to 3026 507 to 21   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 487/489
(99 %)
0 diff
(100 %id)
BQ772955 Chondrosarcoma Cell line .b 2540 to 3026 505 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 487/487
(100 %)
1 diff
(99.8 %id)
BU620377 cell lines, Chondrosarcoma .b 2540 to 3026 505 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
CD365375 Alveolar Macrophage, lung .b 2540 to 3031 510 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 492/492
(100 %)
0 diff
(100 %id)
AI366329 brain, oligodendroglioma .b 2541 to 3010 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AW025997 Kidney .b 2541 to 3026 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AI808743 pooled .b 2542 to 3029 491 to 4       488/491
(99 %)
0 diff
(100 %id)
BQ016273 lung, Metastatic Chondrosarcoma .b 2542 to 3028 503 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
AA809785 germinal center B cell .b 2543 to 3027 491 to 9       483/491
(98 %)
0 diff
(100 %id)
AI015844   .b 2544 to 3029 488 to 4       485/488
(99 %)
0 diff
(100 %id)
BM708521 eye, RPE and Choroid .b 2545 to 3028 1 to 484   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 484/484
(100 %)
0 diff
(100 %id)
BU626105 cell lines, Enchondroma .b 2545 to 3026 500 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 482/482
(100 %)
1 diff
(99.8 %id)
BQ017052 lung, Metastatic Chondrosarcoma .b 2547 to 3026 498 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
DB572387 hypothalamus .b 2548 to 3026 1 to 479     Submitted on the opposite strand 479/479
(100 %)
3 diff
(99.4 %id)
TI_154114109   .b 2551 to 3028 563 to 86   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
AA621770   .b 2552 to 3027 476 to 3       474/476
(99 %)
0 diff
(100 %id)
DB543281 hippocampus .b 2555 to 3026 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
DB551919 hippocampus .b 2555 to 3028 1 to 474     Submitted on the opposite strand 474/474
(100 %)
1 diff
(99.8 %id)
AI924368 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 2556 to 3027 472 to 1       472/472
(100 %)
0 diff
(100 %id)
BQ446420 Knee, Osteoarthritic Cartilage .b 2556 to 3026 489 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
AI089643 uterus .b 2557 to 3028 472 to 1       472/472
(100 %)
6 diff
(98.8 %id)
AI127945 uterus .b 2557 to 3026 483 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 469/469
(100 %)
1 diff
(99.8 %id)
AI566864 anaplastic oligodendroglioma, brain .b 2558 to 3026 469 to 1       469/469
(100 %)
0 diff
(100 %id)
DB541915 hippocampus .b 2560 to 3026 1 to 467     Submitted on the opposite strand 467/467
(100 %)
2 diff
(99.6 %id)
DB552049 hippocampus .b 2560 to 3028 1 to 469     Submitted on the opposite strand 469/469
(100 %)
1 diff
(99.8 %id)
AI697272 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2560 to 3029 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI281467 follicular lymphoma, lymph node .b 2561 to 3032 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AI475576 B-cell, chronic lymphotic leukemia .b 2561 to 3032 480 to 9     Submitted on the opposite strand 472/480
(98 %)
0 diff
(100 %id)
AA554620 lung, lung tumor .b 2562 to 3026 465 to 2       464/465
(99 %)
0 diff
(100 %id)
AI623887 adenocarcinoma, Pancreas .b 2562 to 3027 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI499743 anaplastic oligodendroglioma, brain .b 2563 to 3029 468 to 2       467/468
(99 %)
0 diff
(100 %id)
DB527842 testis .b 2564 to 3026 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AW104418 pooled .b 2568 to 3026 459 to 1       459/459
(100 %)
5 diff
(99.0 %id)
DB552025 hippocampus .b 2569 to 3031 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
CA448953 Chondrosarcoma, Left Pelvis .b 2572 to 3028 473 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 457/457
(100 %)
1 diff
(99.8 %id)
CA433697 mixed .b 2573 to 3028 472 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 456/456
(100 %)
1 diff
(99.8 %id)
AI623140 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2575 to 3028 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AI222043 pooled .b 2576 to 3029 456 to 3       454/456
(99 %)
0 diff
(100 %id)
BQ775069 Bone, Human Chondrosarcoma Cell Line .b 2576 to 3026 469 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 451/451
(100 %)
1 diff
(99.8 %id)
DB543686 hippocampus .b 2577 to 3031 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
AI610810 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2581 to 3026 445 to 1       445/445
(100 %)
3 diff
(99.4 %id)
DB546112 hippocampus .b 2586 to 3028 1 to 443     Submitted on the opposite strand 443/443
(100 %)
1 diff
(99.8 %id)
AW007440 adenocarcinoma, Pancreas .b 2588 to 3029 447 to 5       443/447
(99 %)
0 diff
(100 %id)
BP386751 pancreatic islet .b 2591 to 3027 1 to 437     Submitted on the opposite strand 437/442
(98 %)
1 diff
(99.8 %id)
DB544785 hippocampus .b 2592 to 3028 1 to 437     Submitted on the opposite strand 437/437
(100 %)
3 diff
(99.4 %id)
BM151037 leukopheresis .b 2593 to 3029 452 to 16       437/452
(96 %)
0 diff
(100 %id)
DB515064 testis .b 2594 to 3024 1 to 431     Submitted on the opposite strand 431/433
(99 %)
3 diff
(99.4 %id)
AA938410 carcinoid, lung .b 2595 to 3026 443 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 432/432
(100 %)
1 diff
(99.8 %id)
AI149618   .b 2598 to 3026 441 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 427/429
(99 %)
0 diff
(100 %id)
DB547257 hippocampus .b 2603 to 3026 1 to 424     Submitted on the opposite strand 424/424
(100 %)
1 diff
(99.8 %id)
AI355308 lung .b 2603 to 3027 425 to 1       425/426
(99 %)
3 diff
(99.3 %id)
FN046642 breast carcinoma .b 2605 to 2679 85 to 12     Submitted on the opposite strand 74/87
(85 %)
0 diff
(100 %id)
AI684929 pooled .b 2605 to 3025 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
H01619 placenta .b 2608 to 2860 1 to 262   fully sequenced,   262/262
(100 %)
7 diff
(97.4 %id)
N21240 melanocyte .b 2609 to 3026 418 to 1   fully sequenced,   418/418
(100 %)
5 diff
(98.9 %id)
AA311236   .b 2610 to 3026 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
DB508496 testis .b 2610 to 3028 1 to 419     Submitted on the opposite strand 419/419
(100 %)
4 diff
(99.1 %id)
AI127753 uterus .b 2610 to 3026 430 to 15   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 416/416
(100 %)
1 diff
(99.8 %id)
AI277839 placenta .b 2610 to 3027 424 to 7       418/424
(98 %)
0 diff
(100 %id)
AW516925 cervix .b 2610 to 3027 419 to 2       418/419
(99 %)
0 diff
(100 %id)
AI285096 adenocarcinoma, colon .b 2611 to 3026 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
DB508936 testis .b 2612 to 3026 1 to 413     Submitted on the opposite strand 413/413
(100 %)
3 diff
(99.3 %id)
AI148812 placenta .b 2612 to 3027 418 to 3       416/418
(99 %)
0 diff
(100 %id)
AI086946 senescent fibroblast .b 2613 to 3028 427 to 12   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 416/416
(100 %)
0 diff
(100 %id)
AW241847 pooled .b 2615 to 3029 421 to 6       416/421
(98 %)
0 diff
(100 %id)
DB514594 testis .b 2616 to 3028 1 to 409     Submitted on the opposite strand 409/409
(100 %)
4 diff
(99.1 %id)
AI686541 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2618 to 3028 423 to 13   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 411/411
(100 %)
4 diff
(99.1 %id)
AW337276 adenocarcinoma, Pancreas .b 2619 to 3031 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
AA586337 ovary, ovary bulk tumor .b 2621 to 3029 409 to 1       409/409
(100 %)
0 diff
(100 %id)
BE045838 follicular carcinoma, thyroid .b 2623 to 3029 415 to 8       408/415
(98 %)
0 diff
(100 %id)
AI027244   .b 2624 to 3028 420 to 16   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
AA862097 squamous cell carcinoma from base of tongue, tongue .b 2626 to 3026 401 to 1       401/401
(100 %)
4 diff
(99.1 %id)
AW149378 brain, medulloblastoma .b 2641 to 3026 386 to 1       386/386
(100 %)
6 diff
(98.5 %id)
CN429678 embryonic stem cells, DMSO-treated H9 cellline .b 2642 to 2853 1 to 212       212/212
(100 %)
0 diff
(100 %id)
AA126487 uterus .b 2645 to 3028 383 to 1   fully sequenced,   383/383
(100 %)
0 diff
(100 %id)
AI804891 Prostate .b 2645 to 3032 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AA769693 2 pooled tumors (clear cell type), Kidney .b 2646 to 3029 386 to 3       384/386
(99 %)
0 diff
(100 %id)
BF570121 Kidney, renal carcinoma (ascites) .b 2648 to 2979 333 to 1   fully sequenced, Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 333/333
(100 %)
4 diff
(98.8 %id)
AW264503 brain, three pooled meningiomas .b 2649 to 3026 378 to 1       378/389
(97 %)
0 diff
(100 %id)
AA947234 adenocarcinoma, colon .b 2652 to 3026 375 to 1       375/375
(100 %)
0 diff
(100 %id)
H02167 placenta .b 2657 to 3028 375 to 1   fully sequenced,   375/375
(100 %)
9 diff
(97.6 %id)
AI382138 pooled .b 2658 to 3026 379 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
AW591314 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2668 to 3031 365 to 1       365/365
(100 %)
5 diff
(98.7 %id)
BM991140 lung, Lung Focal Fibrosis .b 2668 to 2972 1 to 304     Submitted on the opposite strand 304/311
(97 %)
8 diff
(97.5 %id)
CA440315 lung, Lung Focal Fibrosis .b 2668 to 3031 1 to 366   AAA Submitted on the opposite strand 366/366
(100 %)
10 diff
(97.3 %id)
AA884398 pooled .b 2669 to 3026 367 to 11   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 357/357
(100 %)
5 diff
(98.6 %id)
DB377840 placenta .b 2669 to 3026 358 to 1       358/358
(100 %)
6 diff
(98.4 %id)
AA488300   .b 2670 to 3029 363 to 5       359/363
(98 %)
0 diff
(100 %id)
AW873572 pooled .b 2675 to 3027 357 to 5       353/357
(98 %)
0 diff
(100 %id)
R35229 placenta .b 2688 to 3004 326 to 1   fully sequenced,   326/326
(100 %)
4 diff
(98.8 %id)
AW015731   .b 2688 to 3026 360 to 22   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 339/341
(99 %)
0 diff
(100 %id)
BM144700 leukopheresis .b 2694 to 3026 350 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 334/339
(98 %)
4 diff
(98.9 %id)
AA626889 bone marrow stroma .b 2696 to 3027 330 to 1       330/330
(100 %)
2 diff
(99.4 %id)
AI223181 pooled .b 2703 to 3031 329 to 1       329/329
(100 %)
0 diff
(100 %id)
CA436672 Bone, Subchondral Bone .b 2704 to 3031 346 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 328/328
(100 %)
0 diff
(100 %id)
BE328326 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 2705 to 3028 324 to 1       324/324
(100 %)
3 diff
(99.1 %id)
BG152475 brain, glioblastoma without EGFR amplification .b 2706 to 3027 323 to 2       322/323
(99 %)
0 diff
(100 %id)
AW241723 pooled .b 2707 to 3026 332 to 13   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 320/322
(99 %)
0 diff
(100 %id)
AI814798 adenocarcinoma, Pancreas .b 2708 to 3026 337 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 319/321
(99 %)
0 diff
(100 %id)
AW513949 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2709 to 3029 321 to 1       321/322
(99 %)
3 diff
(99.1 %id)
BE042653 colon, moderately-differentiated adenocarcinoma .b 2709 to 3028 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AW168374 bowel (skin primary), metastatic melanoma to bowel .b 2712 to 3026 315 to 1       315/315
(100 %)
1 diff
(99.7 %id)
AI915326 pooled .b 2713 to 3002 293 to 5       289/293
(98 %)
0 diff
(100 %id)
CA446484 Chondrosarcoma, Left Pubic Bone .b 2716 to 3026 329 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
T32979 brain .b 2717 to 3031 315 to 1       315/315
(100 %)
0 diff
(100 %id)
BM995470 lung, Metastatic Chondrosarcoma .b 2718 to 3031 333 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 315/318
(99 %)
4 diff
(98.8 %id)
AW207353   .b 2721 to 3032 333 to 22   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 312/316
(98 %)
0 diff
(100 %id)
T73071 Liver .b 2739 to 3026 292 to 1   fully sequenced,   292/292
(100 %)
5 diff
(98.3 %id)
AA878190 carcinoid, lung .b 2742 to 3025 283 to 1       283/283
(100 %)
2 diff
(99.3 %id)
BP389799 pancreatic islet .b 2743 to 2969 1 to 227     Submitted on the opposite strand 227/229
(99 %)
1 diff
(99.6 %id)
AI381188   .b 2743 to 3026 289 to 6       284/289
(98 %)
0 diff
(100 %id)
AW768957 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 2743 to 3026 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AA460015   .b 2746 to 3027 285 to 3       283/285
(99 %)
0 diff
(100 %id)
R66152 placenta .b 2752 to 3026 294 to 1   fully sequenced,   294/294
(100 %)
6 diff
(98.0 %id)
AI205692   .b 2760 to 3027 274 to 6       269/274
(98 %)
0 diff
(100 %id)
AI784009 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2787 to 3026 241 to 1       241/241
(100 %)
1 diff
(99.6 %id)
R70547 placenta .b 2792 to 3013 223 to 1   fully sequenced,   223/223
(100 %)
1 diff
(99.6 %id)
AA460300   .b 2792 to 3030 238 to 1   fully sequenced,   238/238
(100 %)
3 diff
(98.8 %id)
AA524269 colon .b 2795 to 3026 264 to 34   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 231/231
(100 %)
2 diff
(99.2 %id)
AI624089 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2804 to 3029 227 to 2       226/227
(99 %)
0 diff
(100 %id)
AA301751 aorta .b 2815 to 3026 1 to 212       212/212
(100 %)
0 diff
(100 %id)
BM144865 leukopheresis .b 2816 to 3026 226 to 16   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 211/211
(100 %)
0 diff
(100 %id)
AA282993 ovarian tumor, ovary .b 2823 to 3026 204 to 1       204/204
(100 %)
0 diff
(100 %id)
H01513 placenta .b 2830 to 3019 194 to 1   fully sequenced,   194/194
(100 %)
3 diff
(98.5 %id)
AI245827 Kidney .b 2830 to 3026 197 to 1       197/197
(100 %)
0 diff
(100 %id)
AI424609 brain, glioblastoma (pooled) .b 2872 to 3028 158 to 1       158/158
(100 %)
1 diff
(99.4 %id)
DA796086 brain .c 1 to 550 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
CR596089 B cells (Ramos cell line) Cot 25-normalized .c 463 to 2739 1 to 2277   tiling clone,   2277/2277
(100 %)
0 diff
(100 %id)
BX363974   .c 463 to 1412 1 to 949       949/949
(100 %)
1 diff
(99.9 %id)
AK299142   .d 1 to 1979 1 to 1979 W239L S307P tiling clone,   1979/1979
(100 %)
3 diff
(99.9 %id)
CB045632 colon, juvenile granulosa tumor .d 11 to 532 11 to 532     Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 522/532
(98 %)
6 diff
(98.9 %id)
BQ222944 embryonal carcinoma, cell line, testis .d 105 to 611 1 to 512       511/1276
(40 %)
16 diff
(98.8 %id)
CB045631 colon, juvenile granulosa tumor .d 1919 to 2402 501 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 484/484
(100 %)
0 diff
(100 %id)
BI460578 testis .e 1 to 854 2 to 864   tiling clone,   864/896
(96 %)
28 diff
(96.9 %id)
BI464691 testis .e 14 to 802 1 to 801   tiling clone,   801/801
(100 %)
42 diff
(94.8 %id)
BI461762 testis .e 14 to 524 1 to 502       504/507
(99 %)
17 diff
(96.7 %id)
AW363793 colon .e 706 to 1364 15 to 668   tiling clone,   654/668
(97 %)
13 diff
(98.1 %id)
CX755660 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 1287 to 2028 40 to 776   tiling clone, Submitted on the opposite strand 737/776
(94 %)
11 diff
(98.6 %id)
AW361995 colon .e 1484 to 2149 656 to 1       658/658
(100 %)
21 diff
(96.9 %id)
CO247484 Chondrosarcoma Lung Metastasis cell lines, lung .e 1520 to 2261 43 to 773   tiling clone,   731/874
(83 %)
26 diff
(97.1 %id)
AK310741 thymus .f 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
0 diff
(100 %id)
DB162572 thymus .f 2 to 580 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA433606 tongue, tumor tissue .f 10 to 553 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BI766256 pooled lung and spleen .f 16 to 741 1 to 732   tiling clone,   732/732
(100 %)
18 diff
(97.6 %id)
TI_57177761   .f 16 to 741 67 to 798       732/798
(91 %)
21 diff
(97.4 %id)
AK296153 thalamus .f 645 to 2556 1 to 1912 A442V tiling clone,   1912/1912
(100 %)
1 diff
(100.0 %id)
DC340301 thalamus .f 645 to 1285 1 to 641       641/641
(100 %)
0 diff
(100 %id)
CD244647 testis .g 1 to 757 16 to 776   tiling clone,   761/908
(83 %)
12 diff
(98.7 %id)
BX096657 whole brain .g 419 to 942 20 to 543   tiling clone,   524/543
(96 %)
6 diff
(98.9 %id)
AW802727 uterus .g 658 to 1010 17 to 368       352/368
(95 %)
6 diff
(98.4 %id)
BE079405 breast .g 859 to 1166 311 to 5   tiling clone, Submitted on the opposite strand 307/311
(98 %)
0 diff
(100 %id)
BF891847 marrow .g 967 to 1441 1 to 489       489/489
(100 %)
38 diff
(92.3 %id)
BF836738 head_neck .g 974 to 1375 412 to 12   tiling clone, Submitted on the opposite strand 401/420
(95 %)
3 diff
(99.3 %id)
BF834570 head_neck .g 1002 to 1387 1 to 386       386/386
(100 %)
8 diff
(98.0 %id)
BG991670 head_neck .g 1002 to 1387 1 to 386       386/386
(100 %)
8 diff
(98.0 %id)
AW361198 colon .g 1030 to 1595 1 to 568       568/568
(100 %)
6 diff
(99.0 %id)
CB958594 Pooled-Glandular .g 1076 to 1829 1 to 756       756/757
(99 %)
6 diff
(99.3 %id)
BX386475 Placenta Cot 25-normalized .g 1117 to 2099 981 to 1       981/981
(100 %)
6 diff
(99.4 %id)
BF229076 amnion_normal .g 1131 to 1353 225 to 2       224/230
(97 %)
2 diff
(99.2 %id)
BX382585 Placenta Cot 25-normalized .g 1139 to 2085 941 to 1       941/956
(98 %)
13 diff
(98.7 %id)
BG748902 eye, normal pigmented retinal epithelium .g 1140 to 1901 1 to 761       761/761
(100 %)
6 diff
(99.3 %id)
AW368457 head_neck .g 1147 to 1750 602 to 2       601/602
(99 %)
3 diff
(99.6 %id)
BG568503 Liver .g 1154 to 1852 1 to 696       696/696
(100 %)
7 diff
(99.0 %id)
BM701309 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1158 to 1762 18 to 622       605/622
(97 %)
6 diff
(99.1 %id)
BM831733 stomach .g 1183 to 1684 1 to 502       502/502
(100 %)
0 diff
(100 %id)
TI_227713899   .g 1187 to 2127 1014 to 90   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 925/989
(93 %)
17 diff
(98.3 %id)
BU934647 mixed (pool of 40 RNAs) .g 1200 to 2008 1 to 814       814/815
(99 %)
17 diff
(98.0 %id)
BM715964 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1203 to 1957 1 to 751   tiling clone,   751/753
(99 %)
7 diff
(99.1 %id)
TI_227714939   .g 1209 to 2132 1010 to 96   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 915/1009
(90 %)
24 diff
(97.7 %id)
TI_149301988   .g 1210 to 2129 999 to 94   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 906/963
(94 %)
24 diff
(97.6 %id)
BF349134 head_neck .g 1212 to 1423 212 to 1       212/212
(100 %)
1 diff
(99.6 %id)
BE144266 head_neck .g 1218 to 1758 556 to 17     Submitted on the opposite strand 540/558
(96 %)
0 diff
(100 %id)
BE144270 head_neck .g 1218 to 1767 555 to 5     Submitted on the opposite strand 551/565
(97 %)
0 diff
(100 %id)
BF793556 adrenal cortex carcinoma, cell line, adrenal gland .g 1231 to 1888 1 to 656       656/656
(100 %)
2 diff
(99.7 %id)
BM831298 stomach .g 1245 to 1724 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BM831492 stomach .g 1245 to 1849 1 to 605       605/605
(100 %)
0 diff
(100 %id)
AA368595 placenta .g 1247 to 1507 264 to 1       264/267
(98 %)
6 diff
(97.8 %id)
BE812348 amnion_normal .g 1270 to 1800 546 to 14       533/546
(97 %)
0 diff
(100 %id)
BI009189 kidney_tumor .g 1275 to 1549 308 to 34       275/308
(89 %)
0 diff
(100 %id)
BM690119 eye, human retina .g 1275 to 1727 1 to 453     Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 453/453
(100 %)
9 diff
(98.1 %id)
BF680467 Prostate .g 1310 to 2011 1 to 692       692/859
(80 %)
22 diff
(97.5 %id)
FN161209 breast carcinoma .g 1313 to 1402 1 to 89       89/89
(100 %)
1 diff
(98.9 %id)
N44208 multiple sclerosis lesions .g 1318 to 1694 1 to 375   fully sequenced,   375/375
(100 %)
8 diff
(97.9 %id)
N34315 multiple sclerosis lesions .g 1664 to 2129 467 to 1   fully sequenced,   467/467
(100 %)
5 diff
(99.0 %id)
BM662167 eye, human retina .g 1814 to 2129 332 to 17   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 316/316
(100 %)
3 diff
(99.1 %id)
BI915925 brain .h 1 to 702 1 to 702 G6V G7A S8L A10L D11T ... tiling clone,   702/702
(100 %)
9 diff
(98.8 %id)
TI_57238904   .h 1 to 702 30 to 731 G6V G7A S8L A10L D11T ...     702/731
(96 %)
13 diff
(98.3 %id)
AL602856 human skeletal muscle .i 1 to 490 1 to 490   tiling clone,   490/490
(100 %)
0 diff
(100 %id)
CF785885 mixed .i 471 to 1166 15 to 707   tiling clone,   693/813
(85 %)
10 diff
(98.8 %id)
BI562728 testis .i 798 to 1712 1 to 912   tiling clone,   912/957
(95 %)
24 diff
(97.5 %id)
TI_44351231   .i 802 to 1712 126 to 1033       908/1078
(84 %)
26 diff
(97.6 %id)
FN070920 breast carcinoma .i 1092 to 1152 62 to 1     Submitted on the opposite strand 62/63
(98 %)
1 diff
(98.5 %id)
BP355463   .i 1437 to 2017 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
CN429670 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j -8 to 752 1 to 760 R161K tiling clone,   760/760
(100 %)
2 diff
(99.8 %id)
BP292578 lung .k 1 to 574 1 to 577 exact tiling clone,   577/582
(99 %)
10 diff
(98.3 %id)
BF725831 eye, Iris .l 1 to 448 1 to 448 exact tiling clone,   448/448
(100 %)
0 diff
(100 %id)
DA222142 brain .m 1 to 534 2 to 535   tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
BF743313 breast .m 175 to 595 422 to 1     Submitted on the opposite strand 422/422
(100 %)
5 diff
(98.9 %id)
CN483786 eye .m 385 to 1036 1 to 652 exact tiling clone,   652/652
(100 %)
0 diff
(100 %id)
CD691443 normal nasopharynx .n 1 to 545 22 to 566 S14G Q63R C64G tiling clone,   545/566
(96 %)
10 diff
(98.3 %id)
BX096408 carcinoid, lung .n 12 to 397 1 to 386   tiling clone,   386/386
(100 %)
0 diff
(100 %id)
CD244048 testis .o-u 1 to 845 1 to 848   tiling clone,   848/851
(99 %)
4 diff
(99.6 %id)
AV691256 hepatocellular carcinoma .o-u 86 to 414 1 to 329       329/374
(87 %)
1 diff
(99.8 %id)
DB473154 hippocampus .o-u 616 to 1078 1 to 462   tiling clone,   462/462
(100 %)
2 diff
(99.6 %id)
DB481952 hippocampus .o-u 616 to 1042 1 to 427       427/428
(99 %)
2 diff
(99.6 %id)
AV699416 hepatocellular carcinoma .o-u 953 to 1445 493 to 1 exact tiling clone,   493/655
(75 %)
2 diff
(99.7 %id)
DA312831 hippocampus .p-u 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
AL700914 human skeletal muscle .p-u 50 to 452 1 to 403       403/403
(100 %)
9 diff
(97.8 %id)
DA415768 thalamus .p-u 208 to 753 2 to 547 exact tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
BM151083 leukopheresis .q-u 1 to 469 469 to 1 exact tiling clone,   469/469
(100 %)
0 diff
(100 %id)
AI475520 B-cell, chronic lymphotic leukemia .r-u 1 to 439 438 to 1 D4I S5L S6L A7P V8S ... tiling clone,   438/438
(100 %)
1 diff
(99.8 %id)
AA614260   .r-u 49 to 438 424 to 35   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 390/390
(100 %)
1 diff
(99.8 %id)
BI022954 marrow .s-u 1 to 353 360 to 7 E20D H21M V22Y S23L V24L ... tiling clone,   354/360
(98 %)
0 diff
(100 %id)
BI022993 marrow .s-u 88 to 337 16 to 265   tiling clone,   250/265
(94 %)
6 diff
(97.8 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u, .q-u, .r-u, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI